Interim Results from the Phase 1a/1b Dose-Finding Study of CWP232291 (CWP291) in Relapsed or Refractory Myeloma (RRMM) Alone or in Combination with Lenalidomide and Dexamethasone
Manasanch, Elisabet E., Yoon, Sung-Soo, Min, Chang-Ki, Kim, Jin Seok, Shain, Kenneth H, Hauptschein, Robert, Choi, Jeongeun E, Lee, Kyoung-June
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article